22 April 2019, India:
Japan based M3 has acquired majority stake in Bengaluru-based Neuroglia Health Private Limited (NHPL) which owns and operates “DailyRounds” Mobile App.
The financial details have not been disclosed yet.
This move marks M3’s foray into case-based problem-solving community platform and Medical test preparation business in India, in addition to its existing business Health Impetus Private limited (HIPL), the company said in a statement.
HIPL (under brand name of M3 India) currently runs Online portals that help Indian Doctors stay abreast with the latest in research, medical news, evidence-based medicine, practice guidelines and expert articles etc.
Amit Singh, CEO of HIPL (M3 India), said, “With this majority acquisition, M3 India will now be able to reach out to 450,000 Doctors in India on a consolidated basis, while enhancing the utility and satisfaction levels among Doctors by leveraging the strengths of both platforms.”
Amit Singh, added, “It will also enable M3 India to escalate its marketing support and market research businesses to pharmaceutical and medical devices companies through expansion of doctor membership and enhancement of medical education contents.”
Dr. Deepu Sebin, CEO of NHPL, said, “We are very excited with this development. The Indian Doctor community is very active on DailyRounds and Marrow. With the support of M3 we will be offer better services to the existing Doctors.”
Dr. Deepu Sebin, added, “Further we hope to bring in new Doctors as well. The goal is to be largest Doctor network in India, not just by registered numbers, but in terms of active users as well.”
Neuroglia Health Private Limited (NHPL) operates DailyRounds. It was founded by Deepu Sebin, Nimmi Cherian and Priyaank Choubey.
DailyRounds was part of GSF India’s global accelerator programme.
(Image – DailyRounds)
